1. CELL OF ORIGIN COMBINED WITH CNS INTERNATIONAL PROGNOSTIC INDEX IMPROVES IDENTIFICATION OF DLBCL PATIENTS WITH HIGH CNS RELAPSE RISK AFTER INITIAL IMMUNOCHEMOTHERAPY. (June 2017) Authors: Klanova, M.; Sehn, L.H.; Bence‐Bruckler, I.; Cavallo, F.; Jin, J.; Martelli, M.; Stewart, D.; Vitolo, U.; Zaja, F.; Zhang, Q.; Mattiello, F.; Oestergaard, M.Z.; Fingerle‐Rowson, G.R.; Nielsen, T.; Trneny, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOUBLE‐EXPRESSOR LYMPHOMAS DO NOT HAVE INFERIOR OUTCOME AFTER AUTOLOGOUS STEM‐CELL TRANSPLANT IN THE FIRST LINE TREATMENT. (June 2017) Authors: Trneny, M.; Campr, V.; Pytlik, R.; Klener, P.; Stritesky, J.; Jaksa, R.; Boudova, L.; Benesova, K.; Koren, J.; Trnkova, M.; Blahovcova, P.; Klanova, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA IN THE RANDOMISED PHASE III GALLIUM STUDY: ANALYSIS BY CHEMOTHERAPY REGIMEN. (June 2017) Authors: Hiddemann, W.; Barbui, A.M.; Canales Albendea, M.A.; Cannell, P.K.; Collins, G.P.; Dürig, J.; Forstpointner, R.; Herold, M.; Hertzberg, M.; Klanova, M.; Radford, J.A.; Tobinai, K.; Burciu, A.; Fingerle‐Rowson, G.R.; Nielsen, T.; Wolbers, M.; Marcus, R. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗